Rotavirus oral vaccine

It is a live, oral pentavalent vaccine that contains five rotavirus strains produced by reassortment.

Rotavirus oral vaccine

NA

Rotarix, Rotateq (International)

NA

NA

NA

NAThe vaccination series consists of two 1-mL doses administered orally. The first dose should be administered to infants beginning at 6 weeks of age. There should be an interval of at least 4 weeks between the first and second dose.

It is indicated for prevention of rotavirus gastroenteritis caused by G1, G3, G4, and G9 types in infants

Fussiness, irritability, cough, runny nose, fever, vomiting and diarrhea.  

• Rotavirus vaccines may interact with anti-psoriasis drugs, injectable corticosteroids (oral, inhalation or nasal), chemotherapy drugs, radiation, autoimmune drugs, immunosuppressive drugs and anti-arthritic drugs.

NA

Store at 20-25°C.

Molecular weight

NA

Molecular formula

NA

CAS number

NA

Precautions

Caution should be exercised in patients with poor immunity, history of gastrointestinal disorders and any allergy.